Surgery Partners (SGRY) Debt to Equity (2014 - 2026)

Surgery Partners has disclosed Debt to Equity across 13 years of filings, most recently posting $2.2 for Q1 2026.

• Debt to Equity for Q1 2026 came in at $2.2, up 95.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 (up 95.55% YoY), and the FY2025 annual result was $1.18, up 12.13% from the prior year.
• Debt to Equity came in at $2.2 for Q1 2026 at Surgery Partners, up from $1.18 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $2.2 in Q1 2026 to a low of $0.86 in Q2 2023.
• The 5-year median for Debt to Equity is $1.05 (2024), against an average of $1.22.
• Across the five-year window, Debt to Equity plunged 43.07% in 2023 and jumped 100.91% in 2025, its largest moves.
• Surgery Partners' Debt to Equity stood at $0.89 in 2022, then rose by 2.58% to $0.91 in 2023, then increased by 15.3% to $1.05 in 2024, then grew by 12.13% to $1.18 in 2025, then soared by 86.09% to $2.2 in 2026.
• The last three Debt to Equity figures came in at $2.2 (Q1 2026), $1.18 (Q4 2025), and $2.06 (Q3 2025), per Business Quant data.